United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 23, 2015

 

 

CHINA JO-JO DRUGSTORES, INC.

(Exact name of Registrant as specified in charter)

 

Nevada   001-34711   98-0557852
(State or other jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.)

 

 

1st Floor, Yuzheng Plaza, No. 76, Yuhuangshan Road

Hangzhou, Zhejiang Province, People’s Republic of China

(Address of principal executive offices) (Zip Code)

 

Registrant's telephone number, including area code: +86 (571) 88077078

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)

 

☐ Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On March 23, 2014, the registrant held its annual meeting of shareholders for its fiscal year ended March 31, 2014. A quorum was present at the meeting as required by the Bylaws of the Company, as amended. The final voting results for each matter submitted to a vote of shareholders at the meeting are as follows. No broker non-votes were counted for any of the proposals as the Company chose to.

 

1. A proposal to elect five directors to the registrant’s board of directors to hold office until the next annual meeting and until their successors are duly elected and qualified:

Director’s Name   Votes For    Votes Withheld 
Lei Liu   8,730,391    2,711 
Li Qi   8,730,391    2,711 
Taihong Guo   8,730,391    2,711 
Genghua Gu   8,730,391    2,711 
Zhimin Su   8,730,391    2,711 

2. A proposal to amend the Company’s 2010 Equity Incentive Plan to increase 2,300,000 shares that are available for issuance thereunder:

 

For   Against   Abstain  
8,725,391   2,711   5,000  

 

 

3. A proposal to ratify the appointment of Friedman LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2015:

 

For   Against   Abstain  
8,733,102   --   --  

 

 

4. A proposal to approve, on a non-binding, advisory basis, the compensation of the registrant’s named executive officers:

 

For   Against   Abstain  
8,731,502   1,600   --  

 

 

5. A proposal to approve, on a non-binding, advisory basis, the frequency of the advisory vote on executive compensation:

 

One Year   Two Years Three Years   Abstain  
76,711   8,000 8,387,391   1,000  

  

Pursuant to the foregoing votes, Lei Liu, Li Qi, Taihong Guo, Genghua Gu and Zhimin Su were elected to serve as directors; the Company’s 2010 Equity Incentive Plan was amended to increase 2,300,000 shares that are available for issuance thereunder; Friedman LLP was ratified as the registrant’s independent registered public accounting firm for the fiscal year ending March 31, 2015; the compensation of registrant’s named executive officers was approved; the frequency of the advisory vote on executive compensation was decided to be three years.

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CHINA JO-JO DRUGSTORES, INC.
Date: March 25, 2015  
  By:  /s/ Lei Liu
    Name: Lei Liu
Title: Chief Executive Officer

 

 

3